CAMBRIDGE, England, January 26 /PRNewswire/ --
- Not Intended for Media in Austria, Denmark, Iceland, Norway, Sweden, UK, France, Czech Republic and Switzerland
- First Analgesic Therapy to Combine Oxycodone, a Strong Opioid, With Naloxone, an Opioid Antagonist, Offers a New Treatment Option for Physicians
Mundipharma today announced that 13 countries* to date have received approval of Targin, a new combination therapy designed to control severe chronic pain whilst counteracting opioid-induced constipation, a common and often debilitating side effect associated with opioid treatment.[1],[2],[3] A period of European launches will now be initiated.
To view the Multimedia News Release, please click: http://www.prnewswire.com/mnr/targin/36704/